Emergent BioSolutions | Ventas

Sales Cambio Fecha
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
ALKERMES USD 350.4M 27.08M 2024-03
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
Amarin USD 74.71M 8.66M 2023-12
ANI Pharmaceuticals USD 131.65M 175K 2023-12
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Exact Sciences USD 646.88M 18.55M 2023-12
Exelixis USD 425M 54.65M 2024-03
Glaxosmithkline GBP 8.05B 95M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Ironwood Pharmaceuticals USD 117.55M 3.81M 2023-12
Lonza CHF 3.64B 561M 2023-12
Merck USD 15.8B 1.17B 2024-03
Moderna USD 167B 164.19B 2024-03
Myriad Genetics USD 196.6M 4.7M 2023-12
Neurocrine Biosciences USD 515.3M 100K 2024-03
Pacira USD 181.24M 17.32M 2023-12
Pfizer USD 14.9B 651M 2024-03
PTC Therapeutics USD 210.12M 96.94M 2024-03
Sanofi EUR 10.92B 1.05B 2023-12
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
United Therapeutics USD 677.7M 63M 2024-03



Emergent BioSolutions Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2024.